Final answer:
False (option B). Anti-sense technology is falsely described as injecting good recessive RNA to treat dominant diseases; it actually involves using oligonucleotides to inhibit mRNA translation and protein production related to the disease.
Step-by-step explanation:
The statement that anti-sense technology works by injecting a good recessive RNA copy into a person with a dominant disease is false. Anti-sense therapy involves introducing a nucleic acid sequence complementary to the mRNA of a specific gene. This complementary sequence is known as an antisense oligonucleotide, and it binds to the target gene's mRNA by base pairing, which inhibits the translation of the mRNA, effectively reducing the production of the problem protein. Anti-sense technology is applied to treat various diseases, including cancers and genetic conditions where overexpression of a gene leads to disease symptoms, not by adding a 'good' copy of a gene but by silencing the problematic gene expression.